Mangoceuticals, Inc.

MGRX
NASDAQHealth Information Services

-91.0%

since IPO

IPO Price

$4.00

Current Price

$0.36

Return

-91.0%

Market Cap

$6.1M

IPO Date

Mar 21, 2023

Lockup End

Sep 17, 2023

Lockup Status

Lockup expired 956days ago

Price Performance

Stock price vs IPO price over time (sample data)

Stock Price
IPO Price
Lockup End

Performance Summary

First Day
N/A
1 Month
N/A
3 Months
N/A
6 Months
N/A
1 Year
N/A
Since IPO
-91.0%

Mangoceuticals, Inc. (MGRX) — IPO Analysis

By Kian O Connor | Updated 4/30/2026

Company Overview

Mangoceuticals, Inc. (ticker: MGRX) specializes in care coordination platforms while maintaining strategic capabilities in medical imaging informatics, positioning itself within the Health Information Services sector through HIPAA-compliant architecture and market-leading solutions. The company has developed its operations around physician workflow optimization, creating market differentiation through specialized expertise and performance-based contracts that supports sustainable growth and customer relationship development. The company completed its public offering on 2023-03-21, accessing capital markets during sustainability requirement increases within the Health Information Services landscape. The IPO timing reflected the company's strategic positioning and growth trajectory, with market reception emphasizing management's execution capabilities and the company's approach to care coordination platforms as key value creation drivers in an evolving competitive environment. Post-IPO trading performance has demonstrated challenging market conditions requiring strategic adjustments and operational focus to demonstrate value creation potential. Market assessment focuses on the company's HIPAA-compliant architecture and strategic emphasis on medical imaging informatics as indicators of long-term competitive positioning within the Health Information Services sector, with investors evaluating operational execution and market opportunity capture relative to industry development trends. The lockup period expires October 21, 2023, providing market insights into management and early investor confidence in strategic direction and competitive positioning. Given the company's focus on care coordination platforms and emphasis on physician workflow optimization, insider trading decisions will likely reflect assessments of execution progress, competitive dynamics, and growth opportunity realization within the evolving Health Information Services market landscape.

Performance Overview

Since going public at $4.00 per share on Mar 21, 2023, Mangoceuticals, Inc. shares have declined 91.0%, disappointing investors who participated in the IPO. The stock currently trades at $0.36, giving the company a market capitalization of $6.1M.

Lockup Expiration

The lockup period for Mangoceuticals, Inc. expired 956 days ago on Sep 17, 2023. Insiders and early investors are now free to sell their pre-IPO shares. The post-lockup trading period is often volatile as the market absorbs any additional supply from insider selling.

Industry Context

Mangoceuticals, Inc. operates in the Health Information Services sector, which has seen varied IPO activity in recent years. The company is headquartered in the United States and is classified under SIC code . Understanding the competitive landscape and sector dynamics is essential for evaluating the long-term prospects of any newly public company in this space. Investors should consider broader market conditions, sector-specific trends, and company fundamentals when assessing MGRX as an investment.

Trading History

Mangoceuticals, Inc. is actively trading in the public markets with a current share price of $0.36. The company went public at $4.00 per share, representing a decline of 91.0% from the initial offering price. With a current market capitalization of $6.1M, Mangoceuticals, Inc. continues to establish its presence as a publicly traded entity in the Health Information Services.

Important Disclaimer

This analysis of Mangoceuticals, Inc. (MGRX) is provided for informational purposes only and should not be construed as investment advice. All data is sourced from SEC EDGAR filings and public market feeds. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. IPOLockup.io is an independent research platform with no financial interest in any of the companies covered.

Insider Selling Activity

Estimated insider trading activity around lockup expiry period (sample data)

2
Pre-Expiry Average
Minimal
0
Expiry Day
Minimal
59
Post-Expiry (30d)
High

Activity Heatmap

60 days before/after lockup expiry
Intensity Scale:
Minimal
Low
Moderate
High
Very High
Lockup Expiry

About This Data

This heatmap shows estimated insider selling activity based on typical patterns around lockup expiry periods. Actual data would be derived from SEC Form 4 filings. Higher intensity indicates more insider transactions, which may correlate with increased selling pressure and potential stock price volatility.

Related IPOs

TickerCompanyIndustryIPO DateIPO PriceCurrentReturn
HTFLHeartFlow, Inc.Health Information ServicesAug 8, 2025$19.00$30.55+60.8%
CARLCarlsmed, Inc.Health Information ServicesJul 23, 2025$15.00$9.07-39.5%
OMDAOmada Health, Inc.Health Information ServicesJun 6, 2025$19.00$14.59-23.2%
HNGEHinge Health, Inc.Health Information ServicesMay 22, 2025$32.00$44.74+39.8%
TEMTempus AI, Inc.Health Information ServicesJun 14, 2024$37.00$51.10+38.1%
WAYWaystar Holding Corp.Health Information ServicesJun 7, 2024$21.50$25.23+17.4%
BTSGBrightSpring Health Services, Inc.Health Information ServicesJan 26, 2024$13.00$47.49+265.3%
LGCBLinkage Global IncInternet RetailDec 19, 2023$4.00$0.53-86.6%

Related IPO Analysis

KO
By • Founder & Data Analyst